Skip to main content

Table 2 Comparison of the immunophenotypic markers expression and CBC with clinical parameters in CLL patients

From: Evaluation of immunophenotypic markers and clinico-hematological profile in chronic lymphocytic leukemia: implications for prognosis

Data

p value

Rai stage

Modified Rai stage

Binet stage

Splenomegaly

Lymphadenopathy

CD38

0.618

0.648

0.108

0.507

0.109

CD25

0.610

0.859

0.874

0.345

0.466

Double-positive CD56/CD117

0.573

0.650

0.558

0.211

0.854

WBC count × 103/μL

0.239

0.274

0.272

0.312

0.195

Platelets × 103/μL

< 0.001**

< 0.001**

< 0.001**

0.001**

0.606

Hemoglobin g/dL

< 0.001**

< 0.001**

< 0.001**

0.007**

0.709

ALC × 103/μL

0.241

0.273

0.261

0.289

0.201

ANC × 103/μL

0.254

0.535

0.907

0.145

0.749

PLR × 103/μL

0.014*

0.024*

0.027*

0.033*

0.311

NLR × 103/μL

0.292

0.115

0.147

0.327

0.354

  1. CLL chronic lymphocytic leukemia, WBC white blood cell, ALC absolute lymphocyte count, ANC absolute neutrophil count, PLR platelet/lymphocyte ratio, NLR neutrophil/lymphocyte ratio
  2. *Indicates statistical significance (p < 0.05)
  3. **Indicates statistical significance (p < 0.01)
Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us